Ascensión
López Díaz de Cerio
Profesional Investigadora
Helena
Villanueva Ruiz
Publicaciones en las que colabora con Helena Villanueva Ruiz (13)
2021
2017
-
Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA)
PLoS ONE, Vol. 12, Núm. 9
2016
-
MRP1-CD28 bi-specific oligonucleotide aptamers: Target costimulation to drug-resistant melanoma cancer stem cells
Oncotarget, Vol. 7, Núm. 17, pp. 23182-23196
2015
-
2-fluoro-RNA oligonucleotide CD40 targeted aptamers for the control of B lymphoma and bone-marrow aplasia
Biomaterials, Vol. 67, pp. 274-285
2014
-
Idiotype vaccine production using hybridoma technology
Methods in Molecular Biology, Vol. 1139, pp. 367-387
2013
-
CD28 aptamers as powerful immune response modulators
Molecular Therapy - Nucleic Acids, Vol. 2, pp. e98
-
Successful idiotypic vaccination following stem cell allotransplant in lymphoma
Leukemia and Lymphoma
2011
-
BiovaxID®: A customized idiotype vaccine for the treatment of B-cell lymphoma
Expert Review of Vaccines, Vol. 10, Núm. 12, pp. 1661-1669
-
Idiotype vaccines for lymphoma therapy
Expert Review of Vaccines, Vol. 10, Núm. 6, pp. 801-809
2010
-
Idiotype vaccines for human B-cell malignancies
Current Pharmaceutical Design, Vol. 16, Núm. 3, pp. 300-307
-
Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin's lymphoma
Annals of Oncology, Vol. 21, Núm. 12, pp. 2420-2427
2006
-
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma
Journal of the National Cancer Institute, Vol. 98, Núm. 18, pp. 1292-1301
2004
-
Variations in "rescuability" of immunoglobulin molecules from different forms of human lymphoma: Implications for anti-idiotype vaccine development
Critical Reviews in Oncology/Hematology, Vol. 52, Núm. 1, pp. 1-7